You are here

UTIs

After prior rejection, Iterum nabs long-sought FDA nod for oral UTI drug Orlynvah

Fierce Pharma

Sun, 10/27/24 - 07:48 pm

FDA set to decide on GSK's gepotidacin antibiotic in March

Pharmaphorum

Wed, 10/16/24 - 09:56 am

FDA concerned Iterum’s urinary tract infection drug could cause antimicrobial resistance

Fierce Biotech

Fri, 09/6/24 - 11:48 am

FDA Approves UTILITY’s New Antibiotic for Uncomplicated UTI in Women

BioSpace

Thu, 04/25/24 - 11:37 am

UTILITY Therapeutics

Oral vaccine for UTI is potential alternative to antibiotics, finds 9-year study

Medical Xpress

Mon, 04/8/24 - 12:00 pm

GSK's gepotidacin shows potential in urinary tract infections

Marketscreener

Mon, 04/17/23 - 11:39 am

GSK preps filing for novel antibiotic for urinary tract infections

Pharmaphorum

Mon, 11/7/22 - 10:58 am

Illumina Introduces New Research Test to Address One of the Most Common Infections in the United States

BioSpace

Wed, 11/2/22 - 10:16 am

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Endpoints

Fri, 07/15/22 - 10:55 am

antibiotic resistance

Venatorx hits goal in antibiotic phase 3, clearing path to FDA

Fierce Biotech

Thu, 03/10/22 - 10:29 am

clinical trials

Coming of Phage: Clinical trial underscores safety of technology battling E. coli triggered UTIs

Biopharma Reporter

Thu, 02/25/21 - 10:36 am

Locus Biosciences

precision medicine

clinical trials

Iterum nabs speedy FDA antibiotic review, but follows in the footsteps of bankrupt biotechs

Fierce Biotech

Tue, 01/26/21 - 11:16 am

priority review

Locus Biosciences bags up to $12.1M for CRISPR antibacterial; Old Vertex drug heads to PhIII for dementia

Endpoints

Tue, 11/10/20 - 11:02 am

Locus Biosciences

Vertex Pharmaceuticals

clinical trials

BARDA and Locus in tie-up to tackle UTIs with phages

Biopharma Reporter

Mon, 10/12/20 - 10:30 am

Locus Biosciences

Allecra's Exblifep Effective in Hospital-Based Urinary Tract Infections

BioSpace

Tue, 02/25/20 - 10:23 am

complicated urinary tract infections

clinical trials

After positive panel vote, Shionogi antibiotic scores US approval

Endpoints

Fri, 11/15/19 - 10:50 am

Paratek's top antibiotic fails to clear a key competitive hurdle in head-to-head studies

Endpoints

Fri, 11/1/19 - 10:28 am

Despite worries triggered by imbalance of deaths, Shionogi's antibiotic clears FDA panel vote

Endpoints

Thu, 10/17/19 - 10:28 am

advisory panels

In-house FDA review flags a suspicious imbalance in deaths as Shionogi hunts an OK for antibiotic

Endpoints

Mon, 10/14/19 - 10:26 am

advisory panels

VenatoRx initiates enrollment in phase 3 trial of cefepime/VNRX-5133 in cUTIs

Pharmaceutical Business Review

Fri, 08/30/19 - 01:05 pm

clinical trials

complicated urinary tract infections

Pages